Axial Spondyloarthritis: all 207 studies

Page 1 of 3. Open to participants first (57), then studies with results posted, then the rest; newest registration first within each.

• Surface Topography and Radiographic Spinal Damage in Radiographic Axial SpondyloarthritisRecruitingNCT07855393
• RENEW Intervention for Axial SpondyloarthritisNot yet recruitingNCT07836374Not applicable
• Effects of Land- and Water-Based Exercise in Axial SpondyloarthritisNot yet recruitingNCT07833033Not applicable
• Postural Biofeedback and Exercise in Axial SpondyloarthritisNot yet recruitingNCT07776652Not applicable
• A Pragmatic Trial of Interleukin-17 Inhibition Versus Janus Kinase Inhibition After Tumor Necrosis Factor-alpha Inhibitor Failure in Axial SpondyloarthritisNot yet recruitingNCT07770646Phase 4
• A Study to Assess the Safety of Subcutaneous Secukinumab for Treatment in Adult Indian Participants With Axial Spondyloarthritis (axSpA), Ankylosing Spondylitis (AS), and Non-Radiographic Axial Spondyloarthritis (nr-axSpA)Not yet recruitingNCT07737730
• Multicenter Validation of the 2025 Classification Criteria for Axial SpondyloarthritisRecruitingNCT07724847
• Physical Activity Through Health Technology in Axial SpondyloarthritisRecruitingNCT07642622Not applicable
• Effectiveness and Safety of Acemetacin in Active Axial Spondyloarthritis: A Real-world StudyNot yet recruitingNCT07582146Phase 4
• Exploratory Investigation of the Acceptance and Utility of 14-day Trial Periods and Application-related Outcome Measurement (AbEM) Within the Routine Prescription of the DiGA Axia.RecruitingNCT07561255Not applicable
• A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in AdultsRecruitingNCT07290036Phase 1
• Mediterranean Diet and Disease Activity in Axial Spondyloarthritis Receiving Biologic TherapyNot yet recruitingNCT07170384Not applicable
• REDO-JAK: Dose Reduction of Janus Kinase Inhibitors in Patients With Inflammatory Rheumatic DiseasesRecruitingNCT07160231Phase 4
• Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic DiseasesRecruitingNCT07087912Phase 4
• EAST-1 (ERAP-inhibition in Axial Spondyloarthritis Trial - 1)RecruitingNCT07047703Phase 1/2
• Impact Of Upadacitinib On The Frequency Of Acute Recurrent Anterior Uveitis In Patients With Axial SpondyloarthritisNot yet recruitingNCT07018206Phase 4
• Assessing the Feasibility of the Patient-Reported Outcomes Based Model for Community Care of Patients With Axial Spondyloarthritis Via a Type 1 Pilot Hybrid Effectiveness-Implementation Trial Using the RE-AIM FrameworkNot yet recruitingNCT06968247Not applicable
• Exploring the Feasibility and Acceptability of Virtual Reality Exercise for Pain Management, Fear of Movement, Mobility, and Proprioception Deficit in Axial Spondyloarthritis Patients During Flares: Twics DesignNot yet recruitingNCT06967077Not applicable
• A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)RecruitingNCT06888193Phase 1
• A Trial of SHR-1314 Injection in Adult Patients With Active Non-radiographic Axial SpondyloarthritisRecruitingNCT06860750Phase 3
• The Disease Progression of Chinese Axial Spondyloarthritis in a Real-word Cohort StudyRecruitingNCT06844643
• A LONGITUDINAL OBSERVATIONAL STUDY to EVALUATE the EFFICACY of MOVEMENT and IMPLEMENT CONCRETE MOVEMENT RECOMMENDATIONS with the HELP of MOBILITY TRACKING with SMARTWATCHES in SUBJECTS with AXIAL SPONDYLOARTHRITISRecruitingNCT06807853
• Factors for the Onset and Course of Axial SpondylitisRecruitingNCT06594107
• Osteosarcopenia in Axial SpondyloarthritisRecruitingNCT06577350
• Integration of Remote Monitoring in the Management of Chronic Immunosuppressive TherapyRecruitingNCT06544343Not applicable
• Effect of a Self-Management Intervention for Patients Newly Diagnosed With Inflammatory Arthritis: The NISMA TrialRecruitingNCT06533423Not applicable
• Vilamakitug in Spondyloarthritis Placebo-controlled Investigation for EfficacyNot yet recruitingNCT06526377Phase 2
• Barriers and Faciliators for Physical Activity in People With RMDsNot yet recruitingNCT06514443
• axSEND: Exploring Immune and Microbiota Effects of a Partial Enteral Nutrition Diet in Axial SpondyloarthritisRecruitingNCT06460805Not applicable
• A Study to Evaluate the Impact of Upadacitinib on Spondyloarthritis Outcomes in Patients With Active Psoriatic ArthritisRecruitingNCT06454188Phase 4
• Fecal Microbiota Transplantation in Axial SpondyloarthritisRecruitingNCT06451588Phase 2
• Spondyloarthritis Inception Cohort of Southern DenmarkEnrolling by invitationNCT06337513Not applicable
• Severity Over Time of Early Forms of SpondyloarthritisNot yet recruitingNCT06261931
• Influence of Sodium Intake in spondyLoarthriTesRecruitingNCT06259890Not applicable
• A Study to Evaluate 608 in Patients With Non- Radiographic Axial Spondyloarthritis (Nr-axSpA)RecruitingNCT06222671Phase 2
• Efficacy and Safety of SCT650C in Participants With Axial SpondyloarthritisNot yet recruitingNCT06197009Phase 2
• The Effect of Aerobic Exercises and Yoga Exercises in Axial SpondyloarthritisRecruitingNCT06138717Not applicable
• Baricitinib in the Treatment of Refractory Axial Spondyloarthritis Patients: A Comparison With TofacitinibRecruitingNCT06114407Phase 2
• ToFAcitinib in Early Active Axial SpondyloarThritis:RecruitingNCT06112665Phase 4
• Effects of Yoga Therapy in Rehabilitation Compared to Physiotherapy in Moderate Axial Spondyloarthritis (axSPA)RecruitingNCT06083090Not applicable
• Cohort Project of Patients With Inflammatory RheumatismNot yet recruitingNCT06059430
• Characterizing Spondyloarthritis With 68Ga-FAPI PET/CTRecruitingNCT05999643Not applicable
• Chinese Spondyloarthritis Inception Cohort (CESPIC)Not yet recruitingNCT05960864
• High-intensity Training in Patients With Spondyloarthritis: a Randomized Controlled TrialRecruitingNCT05781763Not applicable
• British Axial Spondyloarthritis Inception CohortRecruitingNCT05676775
• The Efficacy of Fecal Microbiota Transplatation on Axial Spondyloarthritis Patients Resistant to Conventional TreatmentRecruitingNCT05654753Phase 2/3
• The Role of IL-23 in Chronic Inflammatory Disease: Exploring the Cellular and Molecular Targets of IL-23 Signaling in Peripheral and Axial SpondyloarthritisRecruitingNCT05290363Not applicable
• Biomedicines and Bacterial Translocation in SpondyloarthritisRecruitingNCT05244109Not applicable
• Clinical Trial of Electroacupuncture in Axial Spondyloarthritis (E-AcuSpA)RecruitingNCT04519866Not applicable
• Advanced Sensor Based Functional ASsessmenTs in Axial SpondyloarthritisRecruitingNCT04489342
• Efficacy of Non-invasive Vagus Nerve Stimulation for Axial Spondyloarthritis Resistant to BiotherapiesNot yet recruitingNCT04286373Not applicable
• Impact of a Gluten-free Diet on Quality of Life in Patients With Axial Spondyloarthritis.RecruitingNCT04274374Not applicable
• Expanded Access to UpadacitinibAvailableNCT04159597
• Fatigue and Skeletal Muscle Impact in Severe Axial SpondyloarthritisRecruitingNCT03940911Not applicable
• Effects of Nonsteroidal Anti-Inflammatory Drugs in Recurrence of Spondyloarthritis Patients After RemissionRecruitingNCT03425812Not applicable
• Identification of New Biomarkers to Promote Personalized Treatment of Patients With Inflammatory Rheumatic DiseasesRecruitingNCT03214263
• German Spondyloarthritis Inception CohortRecruitingNCT01277419
• A Study of Ixekizumab (LY2439821) in Chinese Participants With Radiographic Axial SpondyloarthritisCompletedNCT04285229Phase 3Results posted
• A Study to Evaluate Efficacy and Safety of Upadacitinib in Adults With Axial SpondyloarthritisCompletedNCT04169373Phase 3Results posted
• A Study in Pregnant Women With Chronic Inflammatory Diseases Treated With Cimzia (Certolizumab Pegol)CompletedNCT04163016Phase 1Results posted
• Study to Demonstrate the Efficacy, Safety and Tolerability of an Intravenous Regimen of Secukinumab Compared to Placebo in Subjects With Active axSpACompletedNCT04156620Phase 3Results posted
• Individualizing Anti-Inflammatory Medications for Adults With Axial Spondyloarthritis: A Series of N-of 1 TrialsTerminatedNCT04115098Phase 2Results posted
• A Study to Evaluate the Efficacy and Safety of Bimekizumab in Subjects With Active Ankylosing SpondylitisCompletedNCT03928743Phase 3Results posted
• A Study to Evaluate the Efficacy and Safety of Bimekizumab in Subjects With Active Nonradiographic Axial SpondyloarthritisCompletedNCT03928704Phase 3Results posted
• Study to Evaluate the Effect of Filgotinib on Semen Parameters in Adult Males With Active Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, or Non-radiographic Axial SpondyloarthritisCompletedNCT03926195Phase 2Results posted
• AScalate: Treat-to-target in Axial SpondyloarthritisCompletedNCT03906136Phase 3Results posted
• MRE as a Screening Tool for axSpA in IBDCompletedNCT03817983Results posted
• Efficacy and Safety of Namilumab for Moderate-to-severe Axial SpondyloarthritisCompletedNCT03622658Phase 2Results posted
• Non-Steroidal Anti-inflammatory Drugs in Axial SpondyloarthritisTerminatedNCT03473665Phase 4Results posted
• Efficacy of Golimumab in Early Axial Spondyloarthritis in Relation to Gut InflammationCompletedNCT03270501Phase 3Results posted
• A Post-Marketing-Observational Study (PMOS) to Determine the Effectiveness of Combined Adalimumab Treatment and Active Supervised Training in Patients With Axial Spondyloarthritis (axSpA)TerminatedNCT03258814Results posted
• Golimumab (MK-8259 / SCH900259) Treatment Withdrawal in Participants With Non-radiographic Axial Spondyloarthritis (GO-BACK) (MK-8259-038)CompletedNCT03253796Phase 4Results posted
• SKIPPAIN - Speed of Onset of SecuKinumab-Induced Relief From Pain in Patients With AxIal SpoNdyloarthritisCompletedNCT03136861Phase 3Results posted
• A Long Term Extension Study of Ixekizumab (LY2439821) in Participants With Axial SpondyloarthritisCompletedNCT03129100Phase 3Results posted
• PREDICT-SpA - French Epidemiological Study of the Evaluation of the Impact of Fibromyalgia in the TNF Alpha Treatment Effect in Axial Spondyloarthritis in Both Anti-TNF naïve and - Experienced PatientsCompletedNCT03039088Results posted
• A Study to Assess the Effects of Certolizumab Pegol on the Reduction of Anterior Uveitis (AU) Flares in Axial Spondyloarthritis Subjects With a Documented History of AUCompletedNCT03020992Phase 4Results posted
• Efficacy and Safety Study of SUNPG1622TerminatedNCT02980705Phase 2Results posted
• A Study Treating Participants With Early Axial Spondyloarthritis (axSpA) Taking an Intense Treatment Approach Versus Routine TreatmentTerminatedNCT02897115Phase 4Results posted
• Study of Efficacy and Safety of Secukinumab in Psoriatic Arthritis and Axial Spondyloarthritis Patients With Active Enthesitis Including One Achilles Tendon SiteCompletedNCT02771210Phase 3Results posted
• A Study of Ixekizumab (LY2439821) in Participants With Nonradiographic Axial SpondyloarthritisCompletedNCT02757352Phase 3Results posted
• A Study of Ixekizumab (LY2439821) in TNF Inhibitor Experienced Participants With Radiographic Axial SpondyloarthritisCompletedNCT02696798Phase 3Results posted
• A Study of Ixekizumab (LY2439821) in bDMARD-Naive Participants With Radiographic Axial SpondyloarthritisCompletedNCT02696785Phase 3Results posted
• Study of Efficacy and Safety of Secukinumab in Patients With Non-radiographic Axial SpondyloarthritisCompletedNCT02696031Phase 3Results posted
• Multicenter Study Evaluating Certolizumab Pegol Compared to Placebo in Subjects With axSpA Without X-ray Evidence of ASCompletedNCT02552212Phase 3Results posted
• Etanercept Withdrawal And Retreament Study In Subjects With Nr-ax SpACompletedNCT02509026Phase 4Results posted
• Study to Evaluate Maintenance of Sustained Remission of axSpA With CZP Compared to PlaceboCompletedNCT02505542Phase 3Results posted
• A Study To Evaluate The Efficacy Of Enbrel (REGISTERED) Etanercept Over A Period Of 12 Months In The Routine Treatment Of Patients With Rheumatoid Arthritis, Axial Spondyloarthritis, Psoriatic Arthritis, Or Plaque Psoriasis.CompletedNCT02486302Results posted
• A Study to Evaluate the Efficacy and Safety of Ustekinumab in the Treatment of Anti-TNF(Alpha) Refractory Participants With Active Radiographic Axial SpondyloarthritisTerminatedNCT02438787Phase 3Results posted
• A Study to Evaluate the Efficacy and Safety of Ustekinumab in the Treatment of Anti-TNFα Naive Participants With Active Radiographic Axial SpondyloarthritisTerminatedNCT02437162Phase 3Results posted
• An Efficacy and Safety Study of Ustekinumab in Participants With Active Nonradiographic Axial SpondyloarthritisTerminatedNCT02407223Phase 3Results posted
• A Multicenter, Postmarketing Study Evaluating the Concentration of Cimzia® in Mature Breast Milk of Lactating MothersCompletedNCT02154425Phase 1Results posted
• A Multicener, Postmarketing Study Evaluating the Transfer of Cimzia From the Mother to the Infant Via the PlacentaCompletedNCT02019602Phase 1Results posted
• Novel MRI ANd Biomarkers in GOlimumab-treated Patients With Axial SpondyloarthritisCompletedNCT02011386Results posted
• Continuing Versus Withdrawing Adalimumab in Maintaining Remission in Non-Radiographic Axial SpondyloarthritisCompletedNCT01808118Phase 3Results posted
• Effect of Golimumab in Participants With Active Axial Spondyloarthritis (P07642, MK-8259-006)CompletedNCT01453725Phase 3Results posted
• A Study to Evaluate the NSAIDS Sparing Effect of Etanercept in Subjects With Axial SpondyloarthritisCompletedNCT01298531Phase 4Results posted
• Certolizumab Pegol in Subjects With Active Axial SpondyloarthritisCompletedNCT01087762Phase 3Results posted
• Study of Adalimumab in Patients With Axial SpondyloarthritisCompletedNCT00939003Phase 3Results posted
• Infliximab for Treatment of Axial Spondyloarthritis (P05336 AM1)CompletedNCT00844805Phase 3Results posted
• Effects of Pulmonary Rehabilitation Exercises in Patients With Axial SpondyloarthritisActive, not recruitingNCT07847879Not applicable

← Axial Spondyloarthritis overview